{"context":{"query":">>hgnc>>gencc","source_dataset":"hgnc","target_dataset":"gencc"},"stats":{"queried":1,"total":7,"mapped":1},"pagination":{"has_next":false},"schema":"id|gene_symbol|disease_title|classification_title|moi_title|submitter_title","mappings":[{"input":"HGNC:3236","source":"HGNC:3236|epidermal growth factor receptor","targets":["GENCC_000101-HGNC_3236-OMIM_211980-HP_0000006-GENCC_100001|EGFR|lung cancer|Definitive|Autosomal dominant|Ambry Genetics","GENCC_000101-HGNC_3236-OMIM_616069-HP_0000007-GENCC_100003|EGFR|inflammatory skin and bowel disease, neonatal, 2|Moderate|Autosomal recessive|Ambry Genetics","GENCC_000104-HGNC_3236-OMIM_616069-HP_0000007-GENCC_100003|EGFR|inflammatory skin and bowel disease, neonatal, 2|Moderate|Autosomal recessive|Genomics England PanelApp","GENCC_000106-HGNC_3236-OMIM_616069-HP_0000007-GENCC_100002|EGFR|inflammatory skin and bowel disease, neonatal, 2|Strong|Autosomal recessive|Labcorp Genetics (formerly Invitae)","GENCC_000110-HGNC_3236-ORPHANET_294023-HP_0000007-GENCC_100009|EGFR|neonatal inflammatory skin and bowel disease|Supportive|Autosomal recessive|Orphanet","GENCC_000112-HGNC_3236-MONDO_0008903-HP_0000006-GENCC_100001|EGFR|lung cancer|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3236-OMIM_616069-HP_0000007-GENCC_100004|EGFR|inflammatory skin and bowel disease, neonatal, 2|Limited|Autosomal recessive|G2P"]}]}